Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant
Ryan, K. A.; Watson, R. J.; Bewley, K. R.; Burton, C. A.; Carnell, O.; Cavell, B. E.; Challis, A. R.; Coombes, N. S.; Emery, K.; Fell, R.; Fotheringham, S. A.; Gooch, K. E.; Gowan, K.; Handley, A.; Harris, D. J.; Humphreys, R.; Johnson, R.; Knott, D.; Lister, S.; Morley, D.; Ngabo, D.; Osman, K. L.; Paterson, J.; Penn, E. J.; Pullen, S. T.; Richards, K. S.; Shaik, I.; Summers, S.; Thomas, S. R.; Weldon, T.; Wiblin, N. R.; Vipond, R.; Hallis, B.; Funnell, S. G. P.; Hall, Y.
Show abstract
The mutation profile of the SARS-CoV-2 Omicron variant poses a concern for naturally acquired and vaccine-induced immunity. We investigated the ability of prior infection with an early SARS-CoV-2, 99.99% identical to Wuhan-Hu-1, to protect against disease caused by the Omicron variant. We established that infection with Omicron in naive Syrian hamsters resulted in a less severe disease than a comparable dose of prototype SARS-CoV-2 (Australia/VIC01/2020), with fewer clinical signs and less weight loss. We present data to show that these clinical observations were almost absent in convalescent hamsters challenged with the same dose of Omicron 50 days after an initial infection with Australia/VIC01/2020. The data provide evidence for immunity raised against prototype SARS-CoV-2 being protective against Omicron in the Syrian hamster model. Further investigation is required to conclusively determine whether Omicron is less pathogenic in Syrian hamsters and whether this is predictive of pathogenicity in humans.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters 97%
- Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning 96%
- SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney 96%
Similar papers in this journal
- Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant 96%
- Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters 96%
- Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection 95%
Similar papers in this journal
- Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19. 96%
- Prior vaccination with the rVSV-ZEBOV vaccine does not interfere with but improves the efficacy of postexposure antibody treatment in nonhuman primates exposed to Ebola virus 96%
- A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge 95%
Similar papers in this journal
Similar papers in this journal
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model 95%
- Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters 94%
- Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.